pindolol has been researched along with verapamil in 77 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (48.05) | 18.7374 |
| 1990's | 10 (12.99) | 18.2507 |
| 2000's | 15 (19.48) | 29.6817 |
| 2010's | 15 (19.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Caron, G; Ermondi, G | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Akamatsu, M | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bode, ML; Gravestock, D; Hoppe, HC; Khan, T; Moleele, SS; Nkabinde, LA; Pelly, SC; Steenkamp, PA; van der Westhuyzen, CW | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hochrein, H; Lehmann, HU; Witt, E | 1 |
| Henrich, H; Kababgi, MD; Schneider, KW | 1 |
| Arrigo, F; Bramanti, B; Coglitore, S; Consolo, F; Giannetto, M; Melluso, C; Virga, T | 1 |
| Heine, HW; Konrad, A; Lossnitzer, K; Stauch, M; Ziegler, E | 1 |
| Doshchitsin, VL | 1 |
| Greif, S; Harnoncourt, K; Roth, F | 1 |
| Doshchitsin, VL; Fedorova, IF; Gendlin, GE; Pozin, VM; Skuratovskaia, SG | 1 |
| Bernuth, G; Hofstetter, R; Lang, D | 1 |
| Bakran, I; Duraković, Z; Francetić, I; Gjurasin, M; Mohacek, I; Vrhovac, B | 1 |
| Endoh, M; Schümann, HJ; Wagner, J | 1 |
| Clifton, GD; DeMaria, AN; Harrison, MR | 1 |
| Janowsky, DS; Overstreet, DH; Rezvani, AH | 1 |
| Bailey, DG; Carruthers, SG | 1 |
| Arita, M; Hisatome, I; Imanishi, S; Kiyosue, T | 1 |
| Garcia, ML; Kaczorowski, GJ; King, VF; Reuben, JP; Siegl, PK | 1 |
| Kondo, N; Pang, PK; Shibata, S; Tenner, TE | 1 |
| Channer, KS; James, MA; Papouchado, M; Rees, JR | 1 |
| McGourty, JC; Silas, JH; Solomon, SA | 1 |
| Hof, RP | 1 |
| Channer, KS; James, M | 1 |
| Anavekar, SN; Doyle, AE | 1 |
| Hamann, SR; Kaltenborn, KE; McAllister, RG | 1 |
| Bhandari, A; Rahimtoola, SH; Rose, JS; Wu, D | 1 |
| Byon, KY; Fleckenstein, A; Grün, G; Kaufmann, R | 1 |
| Bender, F; Bräuer, B; Brisse, B; Müller, W | 1 |
| Anderson, ST; Federman, J; Harper, RW; Laufer, E; Pitt, A; Wayne, VS | 1 |
| Himori, N; Ishimori, T; Iwamura, M; Izumi, A; Makino, M; Yasuda, K | 1 |
| Magometschnigg, D; Rameis, H | 1 |
| Johnston, DL; Kostuk, WJ; Manyari, DE | 1 |
| Arita, M; Kiyosue, T | 1 |
| Szekeres, L | 1 |
| Lowenthal, DT | 1 |
| Hashimoto, K; Satoh, H | 1 |
| Kodama, I; Kondo, N; Shibata, S | 1 |
| Doyle, AE | 1 |
| Sekeresh, L | 1 |
| Goch, JH; Kowalski, J; Tkaczewski, W; Wichan, P | 1 |
| Ceci, V; Malinconico, U; Masini, V; Milazzotto, F | 1 |
| Camm, J; Martin, A; Wang, R; Ward, D; Washington, H | 1 |
| Jacovella, G; Lax, A; Romei, E; Vajola, SF | 1 |
| Boucher, M; Chapuy, E; Chassaing, C; Duchêne-Marullaz, P | 1 |
| Arita, M; Hisatome, I | 1 |
| Ikegaya, T; Kaneko, M; Kobayashi, A; Nishiyama, T; Yamazaki, N | 1 |
| Giacomini, KM; Ott, RJ | 1 |
| Dimitrow, PP; Dubiel, JS | 1 |
| Fraudeau, C; Luck, G; Mangani, F; Vérette, E | 1 |
| Alova, L; Boyanova, E; Genkova-Papasova, M; Lazarova-Bakarova, MB; Petkova, B; Stancheva, S; Staneva-Stoytcheva, D | 1 |
| Asensi-Bernardi, L; Van Schepdael, A | 1 |
| Cheon, SA; Chung, JF; Joo, MY; Kim, B; Kim, KH; Lee, SJ; Park, SH; Park, TJ; Seo, ES; Sood, AK; Yang, JS; Yoon, CJ | 1 |
4 review(s) available for pindolol and verapamil
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypertension and calcium antagonists.
Topics: Airway Resistance; Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension; Labetalol; Pindolol; Propranolol; Verapamil | 1982 |
Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Pindolol; Verapamil | 1981 |
11 trial(s) available for pindolol and verapamil
| Article | Year |
|---|---|
[The treatment of angina pectoris with a fixed combination of a beta-adrenoceptor blocker and a long-acting nitrate (double-blind trial) (author's transl)].
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pindolol; Verapamil | 1977 |
The effect of propranolol, prindolol, practolol and verapamil versus placebo on exercise induced tachycardia in patients with ventricular preexcitation.
Topics: Adult; Exercise Test; Female; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Practolol; Propranolol; Tachycardia; Tachycardia, Paroxysmal; Verapamil; Wolff-Parkinson-White Syndrome | 1976 |
Interaction between oral verapamil and beta-blockers during submaximal exercise: relevance of ancillary properties.
Topics: Administration, Oral; Adult; Blood Pressure; Double-Blind Method; Drug Interactions; Exercise; Heart; Heart Rate; Humans; Male; Metoprolol; Pindolol; Propranolol; Random Allocation; Verapamil | 1991 |
Improved control of atrial fibrillation with combined pindolol and digoxin therapy.
Topics: Adult; Aged; Atrial Fibrillation; Digoxin; Drug Therapy, Combination; Dyspnea; Female; Heart Rate; Humans; Middle Aged; Pindolol; Verapamil | 1989 |
Evaluation of verapamil in the treatment of hypertension.
Topics: Adult; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Labetalol; Lung Diseases, Obstructive; Male; Middle Aged; Pindolol; Random Allocation; Sodium Chloride Symporter Inhibitors; Verapamil | 1986 |
Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Drug Combinations; Electrophysiology; Female; Heart Conduction System; Humans; Male; Middle Aged; Pindolol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Verapamil | 1986 |
[Therapeutic problems in hyperkinetic heart syndrome].
Topics: Adrenergic beta-Antagonists; Celiprolol; Clinical Trials as Topic; Female; Heart Rate; Humans; Male; Oxprenolol; Pindolol; Propanolamines; Tachycardia; Verapamil | 1984 |
The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Propranolol; Random Allocation; Stroke Volume; Verapamil | 1984 |
[Ergometric test in sympatheticotonia after administration of propranolol, pindolol, verapamil and oxazepam].
Topics: Adolescent; Adrenergic Fibers; Adult; Clinical Trials as Topic; Exercise Test; Heart; Heart Failure; Humans; Male; Oxazepam; Pindolol; Propranolol; Verapamil | 1980 |
Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy.
Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Pindolol; Verapamil | 1981 |
Treatment of chronic atrial fibrillation in the elderly, assessed by ambulatory electrocardiographic monitoring.
Topics: Aged; Atrial Fibrillation; Digoxin; Drug Tolerance; Electrocardiography; Evaluation Studies as Topic; Female; Heart Rate; Humans; Male; Middle Aged; Pindolol; Placebos; Verapamil | 1980 |
63 other study(ies) available for pindolol and verapamil
| Article | Year |
|---|---|
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Cell Line; Cell Survival; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Models, Molecular; Molecular Structure; Pyridines; Reverse Transcriptase Inhibitors; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)].
Topics: Adrenergic beta-Antagonists; Aged; Cardiac Output; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Pindolol; Pyridazines; Verapamil | 1978 |
Effect of beta-sympatholytic agents on vascular responses to noradrenaline and potassium chloride.
Topics: Adrenergic beta-Antagonists; Animals; Depression, Chemical; Female; Intestine, Small; Male; Mesenteric Arteries; Norepinephrine; Pindolol; Potassium Chloride; Practolol; Propranolol; Rats; Stimulation, Chemical; Vasoconstriction; Verapamil | 1978 |
[Prinzmetal's angina. Considerations on a clinical case].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Electrocardiography; Heart; Heparin; Humans; Lidoflazine; Male; Nitrates; Pindolol; Verapamil | 1977 |
[Proceedings: Prevention of myocardial degeneration in a disease model of hereditary cardiomyopathy].
Topics: Animals; Calcium; Cardiomegaly; Cardiomyopathies; Cricetinae; Disease Models, Animal; Heart; Myocardium; Necrosis; Pindolol; Practolol; Propranolol; Verapamil | 1975 |
[Comparative evaluation of new drugs used in the treatment of cardiac arrhythmia].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Ajmaline; Alprenolol; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Barbiturates; Drug Combinations; Drug Evaluation; Humans; Injections, Intramuscular; Injections, Intravenous; Lidocaine; Pindolol; Practolol; Propranolol; Sparteine; Verapamil | 1975 |
[Prevention of ventricular fibrillation in animal experiments].
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Drug Evaluation; Lidocaine; Pindolol; Rats; Ventricular Fibrillation; Verapamil | 1978 |
[Exercise-induced tachyarrhythmic syncopes with sinus bradycardia and normal QT-interval at rest (author's transl)].
Topics: Bradycardia; Child; Electrocardiography; Female; Humans; Male; Physical Exertion; Pindolol; Practolol; Syncope; Tachycardia; Verapamil | 1977 |
Influence of temperature on the positive inotropic effects mediated by alpha-and-beta-adrenoceptors in the isolated rabbit papillary muscle.
Topics: Animals; Calcium; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Isoproterenol; Papillary Muscles; Perfusion; Phentolamine; Phenylephrine; Pindolol; Rabbits; Receptors, Adrenergic; Stimulation, Chemical; Temperature; Verapamil | 1975 |
Hemodynamic effects of calcium channel and beta-receptor antagonists: evaluation by Doppler echocardiography.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Echocardiography, Doppler; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Nifedipine; Pindolol; Propranolol; Verapamil | 1991 |
Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Drinking Behavior; Ethanol; Feeding Behavior; Fluoxetine; Male; Pindolol; Piperazines; Rats; Rats, Inbred Strains; Rats, Wistar; Scopolamine; Self Administration; Serotonin Receptor Agonists; Species Specificity; Verapamil | 1991 |
Isoproterenol inhibits residual fast channel via stimulation of beta-adrenoceptors in guinea-pig ventricular muscle.
Topics: Action Potentials; Animals; Guinea Pigs; Heart; In Vitro Techniques; Ion Channels; Isoproterenol; Kinetics; Pindolol; Potassium; Receptors, Adrenergic, beta; Verapamil | 1985 |
Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzazepines; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium-Transporting ATPases; Diltiazem; Dithiothreitol; Ethylmaleimide; Female; Guinea Pigs; Hydrogen-Ion Concentration; Iodocyanopindolol; Male; Myocardium; Nifedipine; Nitrendipine; Ouabain; Pindolol; Receptors, Nicotinic; Sodium; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Temperature; Verapamil | 1986 |
Electromechanical effects of bPTH-(1-34) on rabbit sinus node cells and guinea pig papillary muscles.
Topics: Action Potentials; Animals; Female; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Papillary Muscles; Parathyroid Hormone; Peptide Fragments; Pindolol; Rabbits; Ryanodine; Sinoatrial Node; Teriparatide; Verapamil | 1988 |
Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Drug Therapy, Combination; Drug Tolerance; Female; Heart; Humans; Male; Metoprolol; Middle Aged; Pindolol; Propranolol; Verapamil | 1985 |
Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Consciousness; Drug Interactions; Hemodynamics; Humans; Isradipine; Oxadiazoles; Pindolol; Propranolol; Rabbits; Verapamil | 1987 |
Pindolol, not verapamil, in combination with digoxin is the treatment of choice in chronic atrial fibrillation.
Topics: Atrial Fibrillation; Chronic Disease; Digoxin; Drug Therapy, Combination; Humans; Pindolol; Verapamil | 1989 |
Hemodynamic and pharmacokinetic aspects of the interactions between verapamil and pindolol.
Topics: Animals; Dogs; Drug Interactions; Hemodynamics; Male; Pindolol; Verapamil | 1987 |
[Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
Topics: Adrenergic beta-Antagonists; Allyl Compounds; Amino Alcohols; Animals; Calcium; Cats; Chick Embryo; Female; Guinea Pigs; Heart; Muscle Contraction; Muscle, Smooth; Papillary Muscles; Pindolol; Potassium; Prenylamine; Propranolol; Propylamines; Rabbits; Rats; Sotalol; Uterus; Verapamil | 1972 |
[Plasma and tissue catecholamine concentration and antiarrhythmic influence on it].
Topics: Animals; Anti-Arrhythmia Agents; Catecholamines; Humans; Lidocaine; Male; Pindolol; Practolol; Rats; Verapamil | 1973 |
Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases.
Topics: Adrenergic beta-Antagonists; Aged; Bradycardia; Coronary Disease; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypotension; Male; Metoprolol; Middle Aged; Pindolol; Verapamil | 1982 |
Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Guinea Pigs; In Vitro Techniques; Male; Pindolol; Platelet Aggregation; Procaine; Propranolol; Verapamil | 1983 |
Modification of "depressed fast channel dependent slow conduction" by lidocaine and verapamil in the presence or absence of catecholamines--evidence for alteration of preferential ionic channels for slow conduction.
Topics: Action Potentials; Animals; Catecholamines; Guinea Pigs; Heart Conduction System; In Vitro Techniques; Ion Channels; Isoproterenol; Lidocaine; Microelectrodes; Myocardial Infarction; Papillary Muscles; Pindolol; Potassium; Verapamil | 1983 |
A pharmacological evaluation of electrical events in the myocardium.
Topics: Animals; Calcium; Cardiac Output; Coronary Circulation; Dogs; Electrocardiography; Heart; Heart Rate; Ion Channels; Lidocaine; Myocardial Contraction; Myocardium; Pindolol; Potassium; Purkinje Fibers; Rabbits; Sinoatrial Node; Sodium-Potassium-Exchanging ATPase; Verapamil | 1982 |
New drugs for hypertension.
Topics: Antihypertensive Agents; Bumetanide; Diltiazem; Dipeptides; Enalapril; Guanabenz; Guanidines; Humans; Indapamide; Labetalol; Nifedipine; Pindolol; Verapamil | 1984 |
Effects of ftorafur and 5-fluorouracil on the canine sinoatrial node.
Topics: Aminophylline; Animals; Calcium; Dogs; Female; Fluorouracil; Heart Atria; Heart Rate; Male; Myocardial Contraction; Pindolol; Sinoatrial Node; Stimulation, Chemical; Tegafur; Verapamil | 1983 |
Effects of amrinone on the transmembrane action potential of rabbit sinus node pacemaker cells.
Topics: Action Potentials; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Female; Heart Conduction System; In Vitro Techniques; Male; Pindolol; Rabbits; Verapamil | 1983 |
[Pharmacologic evaluation of electrical processes in the myocardium].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Electrophysiology; Heart; Heart Conduction System; In Vitro Techniques; Lidocaine; Nitroglycerin; Pindolol; Verapamil | 1982 |
[Effect of single dose administration of a new beta-blockader (pindolol) prior to onset of angina pectoris as evaluated by exercise tests on a bicycle ergometer].
Topics: Angina Pectoris; Drug Evaluation; Electrocardiography; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pindolol; Propranolol; Verapamil | 1980 |
Chronotropic cardiac effects of falipamil in conscious dogs: interactions with the autonomic nervous system and various ionic conductances.
Topics: Animals; Atropine; Autonomic Nervous System; Blood Pressure; Cardiovascular Agents; Dogs; Female; Heart Rate; Ion Channels; Isoindoles; Male; Phthalimides; Pindolol; Quinidine; Receptors, Adrenergic, beta; Receptors, Muscarinic; Stimulation, Chemical; Verapamil | 1994 |
Effects of catecholamines on the residual sodium channel dependent slow conduction in guinea pig ventricular muscles under normoxia and hypoxia.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels; Catecholamines; Dose-Response Relationship, Drug; Gallopamil; Guinea Pigs; Hypoxia; In Vitro Techniques; Isoproterenol; Membrane Potentials; Myocardial Infarction; Myocardium; Norepinephrine; Pindolol; Potassium; Sodium Channels; Verapamil | 1995 |
Verapamil induced reduction of the myocardial beta-adrenoceptor density in BIO 14.6 cardiomyopathic Syrian hamsters.
Topics: Animals; Binding, Competitive; Calcium Channels; Cardiomyopathies; Cricetinae; Disease Models, Animal; Heart; Mesocricetus; Myocardium; Pindolol; Receptors, Adrenergic, beta; Verapamil | 1993 |
Stereoselective interactions of organic cations with the organic cation transporter in OK cells.
Topics: Animals; Biological Transport, Active; Carrier Proteins; Cations; Cell Line; Disopyramide; Kidney; Microvilli; Opossums; Pindolol; Quinine; Stereoisomerism; Tetraethylammonium Compounds; Verapamil | 1993 |
Effects on left ventricular function of pindolol added to verapamil in hypertrophic cardiomyopathy.
Topics: Adult; Analysis of Variance; Cardiomyopathy, Hypertrophic; Diastole; Drug Evaluation; Drug Therapy, Combination; Echocardiography; Female; Humans; Male; Pindolol; Systole; Time Factors; Ventricular Function, Left; Verapamil | 1993 |
On-line column-switching high-performance liquid chromatography analysis of cardiovascular drugs in serum with automated sample clean-up and zone-cutting technique to perform chiral separation.
Topics: Cardiovascular Agents; Chromatography, High Pressure Liquid; Diltiazem; Lidocaine; Linear Models; Metoprolol; Online Systems; Oxprenolol; Pindolol; Sensitivity and Specificity; Stereoisomerism; Verapamil | 1997 |
Effects of beta-adrenoceptor blocker pindolol, calcium antagonist verapamil and their combination on retention in step-down- and shuttle-box-trained rats and on brain biogenic monoamines.
Topics: Adrenergic beta-Antagonists; Animals; Avoidance Learning; Biogenic Monoamines; Brain; Calcium Channel Blockers; Dopamine; Drug Antagonism; Frontal Lobe; Hippocampus; Male; Memory; Norepinephrine; Pindolol; Rats; Rats, Wistar; Serotonin; Verapamil | 1997 |
Chiral separations by non-aqueous capillary electrophoresis in DMSO-based background electrolytes.
Topics: Dimethyl Sulfoxide; Electrolytes; Electrophoresis, Capillary; Fenfluramine; Methanol; Pindolol; Stereoisomerism; Verapamil | 2014 |
NO-dependent attenuation of TPA-induced immunoinflammatory skin changes in Balb/c mice by pindolol, heptaminol or ATRA, but not by verapamil.
Topics: Animals; Female; Fibrosis; Heptaminol; Hyperplasia; Killer Cells, Natural; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pindolol; Skin; Tetradecanoylphorbol Acetate; Tretinoin; Verapamil | 2016 |